Aptose Biosciences APTO

-
-
-
已收盤:-

本益比明細

年季
收盤價
本業佔比%
本益比(近四季)
每股稅後盈餘(元)
營業利益(千)
稅後純益(百萬)
2024Q1 1.66 101.24 -0.73 -9,760 -10
2023Q4 2.54 101.44 -1.44 -12,127 -12
2023Q3 2.80 102.04 -1.67 -11,681 -11
2023Q2 4.64 102.29 -2.25 -14,452 -14
2023Q1 9.60 103.07 -2.22 -14,096 -14
2022Q4 8.70 104.03 -1.63 -10,403 -10
2022Q3 8.93 102.55 -1.58 -10,026 -10
2022Q2 11.13 101.02 -1.79 -10,673 -11
2022Q1 20.40 100.17 -1.80 -11,500 -11
2021Q4 20.25 100.10 -4.05 -24,348 -24
2021Q3 32.70 100.23 -1.95 -11,359 -11
2021Q2 49.80 100.13 -2.25 -13,488 -13
2021Q1 89.62 100.15 -2.70 -16,252 -16
2020Q4 65.70 100.31 -2.40 -14,759 -15
2020Q3 90.00 100.34 -2.25 -13,294 -13
2020Q2 94.65 100.83 -3.15 -15,881 -16
2020Q1 89.10 102.67 -2.25 -11,834 -12
2019Q4 85.05 102.27 -1.95 -7,884 -8
2019Q3 31.27 102.67 -1.80 -7,027 -7
2019Q2 39.15 102.06 -1.95 -6,346 -6